8th ISoP Seminar on Intelligent Automation in Pharmacovigilance5-6 December 2024 | Hybrid Event (In-Person & Virtual) Take advantage of the 30% discount for ISoP Members attending in-person!Join us for this unique and highly focused seminar, now available as a hybrid event – attend in person in Cambridge, MA or virtually from anywhere in the world! […]
Membership
ISoP PV Journal Club Webinar (20 March 2024)
20 March 2024, 08:00 UTC “Maternal and Early-Life Exposure to Antibiotics and the Risk of Autism and Attention-Deficit Hyperactivity Disorder in Childhood: a Swedish Population-Based Cohort Study”Co-authored and presented by Nele Brusselaers from the Karolinska Institutet, Sweden. Register and join us!
ISoP Membership Fee Update: Enhancing Our Commitment to Growth and Innovation in 2024
As part of our commitment to fostering growth, innovation, and sustainability within ISoP, we wanted to inform you about an important update regarding our membership fees. Starting January 2024, there will be an adjustment in our membership fee structure to better align with the evolving needs of our community and to support the ongoing initiatives […]
ISoP General Assembly (GA) unfolded in Bali (Indonesia) on 8 November 2023
The ISoP General Assembly 2023 (GA) took place during the 22nd ISoP Annual Meeting (ISoP 2023). GA Presentation and Minutes are now available on the ISoP Website.
ISoP editorials in Drug Safety journal
Drug Safety is the premier international journal covering the disciplines of pharmacovigilance, pharmacoepidemiology, benefit-risk assessment, risk management and medication error prevention. Drug Safety advances the rational use of pharmacotherapy by publishing reviews and original research articles offering guidance for safe and effective drug utilization and prescribing.
